Back to Trades
Bergman Alan B.
Chief Financial OfficerCIK 0001907908
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 2 filings between 2026, Bergman Alan B., Chief Financial Officer, has disclosed $188.0K in transactions — all concentrated in 20/20 Biolabs, Inc. (AIDX). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Apr 6 | AIDX 20/20 Biolabs, Inc. | Bergman Alan B. | Chief Financial Officer | Award | $188.0K |
| Feb 17 | AIDX 20/20 Biolabs, Inc. | Bergman Alan B. | Chief Financial Officer | Other | $0 |
2 filings